Mariell Jessup

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Guidelines for the management of heart failure: differences in guideline perspectives
    Mariell Jessup
    Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Cardiol Clin 25:497-506; v. 2007
  2. ncbi Resynchronization therapy is an important advance in the management of congestive heart failure: view of an antagonist
    Mariell Jessup
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 14:S30-4. 2003
  3. ncbi Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure
    Mariell Jessup
    Heart Failure Transplant Program, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Circulation 124:304-13. 2011
  4. ncbi Epilogue: support devices for end stage heart failure
    Mariell Jessup
    Heart Failure Transplantation Program, University of Pennsylvania Medical Center, 6 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Cardiol Clin 21:135-9. 2003
  5. ncbi New directions in the medical management of heart failure
    John D Harding
    Cardiovascular Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Semin Thorac Cardiovasc Surg 17:334-42. 2005
  6. ncbi Heart failure
    Mariell Jessup
    Heart Failure-Cardiac Transplantation Program, Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia 19104, USA
    N Engl J Med 348:2007-18. 2003
  7. ncbi Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States
    Michael A Acker
    Division of Cardiothoracic Surgery, University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Ann Thorac Surg 94:2147-58. 2012
  8. ncbi Multiple biomarkers for risk prediction in chronic heart failure
    Bonnie Ky
    Penn Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Circ Heart Fail 5:183-90. 2012
  9. ncbi Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial
    Michael A Acker
    Hospital of the University of Pennsylvania, Cardiothoracic Surgery, 3400 Spruce St, Philadelphia, PA 19104 6070, USA
    J Thorac Cardiovasc Surg 142:569-74, 574.e1. 2011
  10. ncbi Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
    Lee R Goldberg
    University of Pennsylvania School of Medicine, Philadelphia, PA 19104
    Circulation 113:2851-60. 2006

Detail Information

Publications44

  1. ncbi Guidelines for the management of heart failure: differences in guideline perspectives
    Mariell Jessup
    Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Cardiol Clin 25:497-506; v. 2007
    ..Accordingly, many professional organizations, societies, institutions of health care or policy, and even countries have published practice guidelines on a variety of topics, including heart failure...
  2. ncbi Resynchronization therapy is an important advance in the management of congestive heart failure: view of an antagonist
    Mariell Jessup
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 14:S30-4. 2003
    ..The costs of CRT are not negligible. The morbidity and mortality of the procedure to implant these devices must be considered in future trial design...
  3. ncbi Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure
    Mariell Jessup
    Heart Failure Transplant Program, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Circulation 124:304-13. 2011
    ..Adeno-associated virus type 1/sarcoplasmic reticulum Ca(2+)-ATPase was assessed in a randomized, double-blind, placebo-controlled, phase 2 study in patients with advanced heart failure...
  4. ncbi Epilogue: support devices for end stage heart failure
    Mariell Jessup
    Heart Failure Transplantation Program, University of Pennsylvania Medical Center, 6 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Cardiol Clin 21:135-9. 2003
    ..Achievement of the ultimate goals of improved survival and quality of life for patients with advanced heart disease may depend on the strategic use of support devices more frequently than on the total replacement heart...
  5. ncbi New directions in the medical management of heart failure
    John D Harding
    Cardiovascular Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Semin Thorac Cardiovasc Surg 17:334-42. 2005
    ....
  6. ncbi Heart failure
    Mariell Jessup
    Heart Failure-Cardiac Transplantation Program, Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia 19104, USA
    N Engl J Med 348:2007-18. 2003
  7. ncbi Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States
    Michael A Acker
    Division of Cardiothoracic Surgery, University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Ann Thorac Surg 94:2147-58. 2012
    ....
  8. ncbi Multiple biomarkers for risk prediction in chronic heart failure
    Bonnie Ky
    Penn Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Circ Heart Fail 5:183-90. 2012
    ..Prior studies have suggested using a panel of biomarkers that measure diverse biological processes as a prognostic tool in chronic heart failure. Whether this approach improves risk prediction beyond clinical evaluation is unknown...
  9. ncbi Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial
    Michael A Acker
    Hospital of the University of Pennsylvania, Cardiothoracic Surgery, 3400 Spruce St, Philadelphia, PA 19104 6070, USA
    J Thorac Cardiovasc Surg 142:569-74, 574.e1. 2011
    ....
  10. ncbi Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
    Lee R Goldberg
    University of Pennsylvania School of Medicine, Philadelphia, PA 19104
    Circulation 113:2851-60. 2006
  11. ncbi Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary
    Michael A Acker
    Division of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia, PA, USA
    Circ Heart Fail 6:145-50. 2013
    ....
  12. ncbi Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States
    Michael A Acker
    Division of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia, PA, USA
    Circ Heart Fail 6:e1-e11. 2013
    ....
  13. ncbi Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States
    Michael A Acker
    Division of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Heart Lung Transplant 31:1241-52. 2012
    ....
  14. ncbi Practice guidelines: role of internists and primary care physicians
    Shashank Desai
    University of Pennsylvania, Philadelphia, PA 19104, USA
    Med Clin North Am 88:1369-80, xiii. 2004
    ....
  15. ncbi Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender
    Thomas P Cappola
    Division of Cardiovascular Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Card Fail 12:182-8. 2006
    ..Future studies should take these clinical factors into account when determining the influence of genetic factors and novel therapies on ventricular remodeling in chronic heart failure...
  16. ncbi Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure
    Pavan Atluri
    Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Cardiothorac Surg 3:26. 2008
    ..Cardiac retransplantation remains the only viable long-term solution for end-stage cardiac allograft failure. Given the limited number of available donor hearts, the long term results of this treatment option need to be evaluated...
  17. ncbi The new staging system for heart failure. What every primary care physician should know
    Susan C Brozena
    Heart Failure/Transplant Program, Hospital of the University of Pennsylvania, Philadelphia, USA
    Geriatrics 58:31-6; quiz 38. 2003
    ..It is meant to complement the NYHA classification system, which has been used to describe functional limitations, not structural abnormalities...
  18. ncbi Management of prosthetic valves during ventricular assist device implantation
    Tong Liu
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    J Card Surg 25:601-5. 2010
    ..The operative and peri-operative management of these patients has been varied...
  19. ncbi Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure
    John D Harding
    Cardiovascular Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19140, USA
    J Card Fail 11:227-32. 2005
    ..Beyond the impact of myocardial inflammation and wound healing occurring after all LVAD implants, early postoperative increases in the QTc interval after cardiac unloading appear to predispose to ventricular arrhythmias...
  20. ncbi Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary
    Michael A Acker
    Division of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Ann Thorac Surg 94:e163-8. 2012
    ....
  21. ncbi Mechanical circulatory support as a bridge to transplant or for destination therapy
    Satya S Shreenivas
    Department of Medicine, Cardiovascular Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Curr Heart Fail Rep 7:159-66. 2010
    ..In addition to improvement of MCS devices, investigational work continues to achieve appropriate patient selection and complication management...
  22. ncbi The next decade in mechanical assist: advances that will help the patient and the doctor
    Pavan Atluri
    Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania School of Medicine, 3400 Civic Center, Philadelphia, PA 19104, USA
    Curr Opin Cardiol 26:256-60. 2011
    ..Yet, several VAD-specific morbidities and technological challenges, which are reviewed, continue to limit the number of devices that are currently implanted...
  23. ncbi A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home
    Susan C Brozena
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 23:1082-6. 2004
    ..We performed a prospective study to determine the feasibility and safety of continuous intravenous milrinone therapy administered at home in patients listed as Status IB for heart transplant...
  24. ncbi High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure
    Bonnie Ky
    Penn Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Circ Heart Fail 4:180-7. 2011
    ..The use of ST2 in chronic heart failure has not been well defined. Our objective was to determine whether plasma ST2 levels predict adverse outcomes in chronic heart failure in the context of current approaches...
  25. ncbi Acute myocardial infarction requiring mechanical bridge to transplantation in a patient with undiagnosed anti-phospholipid antibody syndrome
    Clifton C Reade
    Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Heart Lung Transplant 27:682-4. 2008
    ..To our knowledge this is the first reported case of severe acute heart failure due to anti-phospholipid antibody syndrome in which the patient survived through assist device placement and successful transplantation...
  26. ncbi History of depression as a predictor of adverse outcomes in patients hospitalized for decompensated heart failure
    Simon de Denus
    Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania 19104, USA
    Pharmacotherapy 24:1306-10. 2004
    ..Our results require confirmation in larger trials...
  27. ncbi Recipient selection in cardiac transplantation: contraindications and risk factors for mortality
    Thomas R Cimato
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Heart Lung Transplant 21:1161-73. 2002
    ..Moreover, as alternative therapies to HTx become reality, a better instrument for triaging patients to one form of therapy or another may be necessary...
  28. ncbi Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial
    Michael A Acker
    Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104-6070, USA
    J Thorac Cardiovasc Surg 132:568-77, 577.e1-4. 2006
    ....
  29. ncbi Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure
    Douglas L Mann
    Center for Heart Failure, Baylor College of Medicine, Houston, Texas 77030, USA
    J Card Fail 10:185-92. 2004
    ....
  30. ncbi Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant can
    Mariell Jessup
    International Society for Heart and Lung Transplantation, Addison, Texas 75001, USA
    J Heart Lung Transplant 25:1003-23. 2006
  31. ncbi Worldwide clinical experience with the CorCap Cardiac Support Device
    Randall C Starling
    Section of Heart Failure and Cardiac Transplant Medicine, Kaufman Center for Heart Failure, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195, USA
    J Card Fail 10:S225-33. 2004
    ..The Acorn CorCap CSD received CE mark approval in Europe in 2001 and has been available to a small number of centers in a Limited Market Release Surveillance Study (LMRSS)...
  32. ncbi Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing Group
    Emelia J Benjamin
    Circulation 111:e124-33. 2005
  33. ncbi Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy
    Douglas L Mann
    Baylor College of Medicine, Houston, Texas, USA
    Ann Thorac Surg 84:1226-35. 2007
    ..Left ventricular (LV) remodeling is related to adverse outcomes in heart failure. The CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, MN) is an implantable device that attenuates LV remodeling...
  34. ncbi Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial
    Randall C Starling
    The Cleveland Clinic, Kaufman Center for Heart Failure, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 84:1236-42. 2007
    ..However, long-term effects in patients with heart failure have not been reported...
  35. ncbi Validation of prognostic models among patients with advanced heart failure
    David S Frankel
    Massachusetts General Hospital, Boston, Massachusetts, USA
    J Card Fail 12:430-8. 2006
    ..There is a need for a contemporary model, derived from a patient population managed in accordance with current heart failure guidelines, applicable to all heart failure etiologies, relying on readily available clinical data...
  36. ncbi Aldosterone blockade and heart failure
    Mariell Jessup
    N Engl J Med 348:1380-2. 2003
  37. ncbi Thoracic organ transplantation
    Richard N Pierson
    University of Maryland Medical Center and VA, Baltimore, MD, USA
    Am J Transplant 4:93-105. 2004
    ..Areas where improved data collection could inform evolving organ allocation and candidate selection policies are emphasized...
  38. ncbi Rationale and process: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006
    Mandeep R Mehra
    International Society for Heart and Lung Transplantation, Addison, Texas 75001, USA
    J Heart Lung Transplant 25:1001-2. 2006
  39. ncbi Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant recipients
    Simon de Denus
    Fellow in Cardiovascular Pharmacotherapy, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19103-4495, USA
    Ann Pharmacother 38:1136-41. 2004
    ..Our results support previous findings that statins are safe and effective in reducing LDL-C in the management of dyslipidemias in OHT recipients. Nonetheless, dyslipidemias are suboptimally managed in many post-OHT patients...
  40. ncbi The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of
    Leslie T Cooper
    J Am Coll Cardiol 50:1914-31. 2007
  41. ncbi Development and validation of a patient questionnaire to determine New York Heart Association classification
    Spencer H Kubo
    Acorn Cardiovascular Inc, St. Paul, Minnesota 55112, USA
    J Card Fail 10:228-35. 2004
    ..This approach may be useful to determine NYHA classification within the context of clinical trials where blinded conditions are not possible...
  42. ncbi A time to be born and a time to die
    Lee R Goldberg
    Circulation 116:360-2. 2007
  43. ncbi Timing the implantation of implantable cardioverter-defibrillators in patients with nonischemic cardiomyopathy
    Francis E Marchlinski
    J Am Coll Cardiol 47:2483-5. 2006
  44. ncbi Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
    Roger J Hajjar
    Mount Sinai School of Medicine, New York, New York 10029, USA
    J Card Fail 14:355-67. 2008
    ..Prior animal and human studies have documented decreased expression of SERCA2a, a major cardiac calcium cycling protein, as a major defect found in HF...